Tizanidine (New Horizon Rx Group, LLC)
Welcome to the PulseAid listing for the Tizanidine drug offered from New Horizon Rx Group, LLC. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | New Horizon Rx Group, LLC |
NON-PROPRIETARY NAME: | Tizanidine |
SUBSTANCE NAME: | TIZANIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-08-25 |
END MARKETING DATE: | 0000-00-00 |
Tizanidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Tizanidine from New Horizon Rx Group, LLC |
LABELER NAME: | New Horizon Rx Group, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2013-08-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58517-380_4ed0bea5-7cc0-4c59-9517-6628c53a27b4 |
PRODUCT NDC: | 58517-380 |
APPLICATION NUMBER: | ANDA076416 |
Other TIZANIDINE Pharmaceutical Manufacturers / Labelers: